Literature DB >> 21315622

Overexpression of μ-calpain in the anterior temporal neocortex of patients with intractable epilepsy correlates with clinicopathological characteristics.

Zhan-hui Feng1, Junwei Hao, Lan Ye, Carlos Dayao, Ning Yan, Yong Yan, Lan Chu, Fu-dong Shi.   

Abstract

PURPOSE: This study aims to investigate μ-calpain expression profiles in the anterior temporal neocortex in patients with intractable epilepsy, and to determine whether its pattern of expression is related to pathological changes seen in these patients.
METHODS: The study subjects consisted of 30 patients with intractable epilepsy and a control group of 10 patients with brain trauma who underwent resection of the anterior temporal lobe. μ-Calpain expression in surgically resected anterior temporal cortices of patients with intractable epilepsy were analyzed using the RT-PCR, Western blot, immunohistochemistry and immunofluorescence staining. GFAP expression was detected by immunohistochemical staining. The related pro-inflammatory cytokines were quantified by elisa. Clinicopathological characteristics were evaluated by HE staining.
RESULTS: Analysis by Western blot and RT-PCR revealed that inactive μ-calpain expression and the calpain-cleaved spectrin fragment in surgically resected anterior temporal cortices of patients with intractable epilepsy were significantly increased compared to the tissues from corresponding regions of the control group. Immunohistological staining demonstrated that μ-calpain was overexpressed in the cell cytoplasm of neurons and glial cells in patients with intractable epilepsy and GFAP was overexpressed in the cell cytoplasm of glial cells in patients with intractable epilepsy. The level of pro-inflammatory cytokines, such as IL-1β, IL-6 and TGF-β1 were significantly increased in patients with intractable epilepsy. HE staining indicated μ-calpain overexpression is an independent prognostic factor for pathological changes such as neuronal loss, neuronal degeneration, gliosis and astrocytosis.
CONCLUSION: These data suggest that overexpression of μ-calpain is relationship with intractable epilepsy as well as the clinicopathological characteristics in these patients.
Copyright © 2011 British Epilepsy Association. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21315622      PMCID: PMC3600948          DOI: 10.1016/j.seizure.2011.01.010

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  34 in total

1.  Cellular injury and neuroinflammation in children with chronic intractable epilepsy.

Authors:  Jieun Choi; Douglas R Nordli; Tord D Alden; Arthur DiPatri; Linda Laux; Kent Kelley; Joshua Rosenow; Stephan U Schuele; Veena Rajaram; Sookyong Koh
Journal:  J Neuroinflammation       Date:  2009-12-19       Impact factor: 8.322

2.  Decreased expression of thyroid receptor-associated protein 220 in temporal lobe tissue of patients with refractory epilepsy.

Authors:  Jin-Mei Li; Xue-Feng Wang; Zhi-Qin Xi; Yun Gong; Feng-Ying Liu; Ji-Jun Sun; Yuan Wu; Guo-Ming Luan; Yu-Ping Wang; Yun-Lin Li; Jian-Guo Zhang; Yong Lu; Hong-Wei Li
Journal:  Biochem Biophys Res Commun       Date:  2006-08-10       Impact factor: 3.575

3.  Quantitative neuropathology of the entorhinal cortex region in patients with hippocampal sclerosis and temporal lobe epilepsy.

Authors:  Stephen Dawodu; Maria Thom
Journal:  Epilepsia       Date:  2005-01       Impact factor: 5.864

4.  Expression of the proto-oncogene bcl-2 is increased in the rat brain following kainate-induced seizures.

Authors:  S H Graham; J Chen; R A Stetler; R L Zhu; K L Jin; R P Simon
Journal:  Restor Neurol Neurosci       Date:  1996-01-01       Impact factor: 2.406

5.  Is the cell death in mesial temporal sclerosis apoptotic?

Authors:  Hilmi Uysal; Isin Unal Cevik; Figen Soylemezoglu; Bulent Elibol; Yasemin Gursoy Ozdemir; Tulay Evrenkaya; Serap Saygi; Turgay Dalkara
Journal:  Epilepsia       Date:  2003-06       Impact factor: 5.864

6.  Mature interleukin-33 is produced by calpain-mediated cleavage in vivo.

Authors:  Morisada Hayakawa; Hiroko Hayakawa; Yasushi Matsuyama; Hiroyuki Tamemoto; Hitoaki Okazaki; Shin-ichi Tominaga
Journal:  Biochem Biophys Res Commun       Date:  2009-07-09       Impact factor: 3.575

7.  Cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion.

Authors:  Ming Sun; Yumei Zhao; Chao Xu
Journal:  Cell Mol Neurobiol       Date:  2007-12-21       Impact factor: 5.046

Review 8.  Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.

Authors:  P S Vosler; C S Brennan; J Chen
Journal:  Mol Neurobiol       Date:  2008-08-07       Impact factor: 5.590

Review 9.  Epilepsy: a review of reports, guidelines, recommendations and models for the provision of care for patients with epilepsy.

Authors:  Rebecca L M Aylward
Journal:  Clin Med (Lond)       Date:  2008-08       Impact factor: 2.659

Review 10.  The calpains: modular designs and functional diversity.

Authors:  Dorothy E Croall; Klaus Ersfeld
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  18 in total

Review 1.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

2.  Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calcium-activated protease calpain.

Authors:  Martin Puskarjov; Faraz Ahmad; Kai Kaila; Peter Blaesse
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

3.  Calpain activation and neuronal death during early epileptogenesis.

Authors:  Philip M Lam; Marco I González
Journal:  Neurobiol Dis       Date:  2018-11-10       Impact factor: 5.996

4.  Astrocyte mitochondria: Central players and potential therapeutic targets for neurodegenerative diseases and injury.

Authors:  J L Gollihue; C M Norris
Journal:  Ageing Res Rev       Date:  2020-02-24       Impact factor: 10.895

5.  Functional validation of a human CAPN5 exome variant by lentiviral transduction into mouse retina.

Authors:  Katherine J Wert; Jessica M Skeie; Alexander G Bassuk; Alicia K Olivier; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mol Genet       Date:  2013-12-30       Impact factor: 6.150

6.  A calpain inhibitor ameliorates seizure burden in an experimental model of temporal lobe epilepsy.

Authors:  Philip M Lam; Jessica Carlsen; Marco I González
Journal:  Neurobiol Dis       Date:  2017-02-22       Impact factor: 5.996

7.  Epilepsy and Alterations of the Blood-Brain Barrier: Cause or Consequence of Epileptic Seizures or Both?

Authors:  Wolfgang Löscher
Journal:  Handb Exp Pharmacol       Date:  2022

Review 8.  Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures.

Authors:  Tarek Z Deeb; Jamie Maguire; Stephen J Moss
Journal:  Epilepsia       Date:  2012-12       Impact factor: 5.864

9.  Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy.

Authors:  Ralf G Rempe; Anika M S Hartz; Emma L B Soldner; Brent S Sokola; Satya R Alluri; Erin L Abner; Richard J Kryscio; Anton Pekcec; Juli Schlichtiger; Björn Bauer
Journal:  J Neurosci       Date:  2018-04-09       Impact factor: 6.167

Review 10.  Cortical inhibition, pH and cell excitability in epilepsy: what are optimal targets for antiepileptic interventions?

Authors:  Ivan Pavlov; Kai Kaila; Dimitri M Kullmann; Richard Miles
Journal:  J Physiol       Date:  2012-08-13       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.